• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

GANCICLOVIR Drug Record

  • Summary
  • Interactions
  • Claims
  • GANCICLOVIR chembl:CHEMBL182 Approved

    Alternate Names:

    RS-21592
    ZIRGAN
    CYTOVENE
    GANCICLOVIR
    VITRASERT
    VIRGAN
    CYMEVENE
    BW-759U
    GANCICLOVIRUM
    GANCYCLOVIR
    2-AMINO-9-(2-HYDROXY-1-HYDROXYMETHYL-ETHOXYMETHYL)-1,9-DIHYDRO-PURIN-6-ONE
    2-AMINO-9-((1,3-DIHYDROXYPROPAN-2-YLOXY)METHYL)-1H-PURIN-6(9H)-ONE
    2-AMINO-9-((1,3-DIHYDROXYPROPAN-2-YLOXY)METHYL)-3H-PURIN-6(9H)-ONE
    9-((2-HYDROXY-1-(HYDROXYMETHYL)ETHOXY)METHYL)GUANINE
    2-AMINO-9-(2-HYDROXY-1-HYDROXYMETHYLETHOXYMETHYL)-6,9-DIHYDRO-1H-6-PURINONE
    2-AMINO-9-((1,3-DIHYDROXYPROPAN-2-YLOXY)METHYL)-9H-PURIN-6-OL
    9-[(1,3-DIHYDROXY-2-PROPOXY)METHYL]GUANINE
    GA2
    2-(6-AMINO-PURIN-9-YLMETHOXY)-PROPANE-1,3-DIOL
    rxcui:4678
    chembl:CHEMBL182
    pubchem.compound:3454
    drugbank:01004
    chemidplus:82410-32-0

    Drug Info:

    (0 More Sources)

    Publications:

    Lung et al., 2000, The cellular oncogene EWS/activating transcription factor 1 is unable to activate adenovirus-borne promoters: implications for cytotoxic prodrug therapy of malignant melanoma of soft parts., Cancer Gene Ther.
    Ring et al., 1996, Suicide gene expression induced in tumour cells transduced with recombinant adenoviral, retroviral and plasmid vectors containing the ERBB2 promoter., Gene Ther.
    Khallou-Laschet et al., 2006, The proatherogenic role of T cells requires cell division and is dependent on the stage of the disease., Arterioscler. Thromb. Vasc. Biol.
    Adachi et al., 2002, Expression of MRP4 confers resistance to ganciclovir and compromises bystander cell killing., J. Biol. Chem.
  • GANCICLOVIR   SST

    Interaction Score: 4.42

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    10766345


    Sources:
    NCI

  • GANCICLOVIR   APOE

    Interaction Score: 1.82

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    16322528


    Sources:
    NCI

  • GANCICLOVIR   ABCC4

    Interaction Score: 1.07

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    12105214


    Sources:
    NCI

  • GANCICLOVIR   ERBB2

    Interaction Score: 0.21

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    8986436


    Sources:
    NCI

  • NCI: GANCICLOVIR

    • Version: 14-September-2017

    Alternate Names:
    C517 NCI drug code

    Drug Info:

    Publications:
    Lung et al., 2000, The cellular oncogene EWS/activating transcription factor 1 is unable to activate adenovirus-borne promoters: implications for cytotoxic prodrug therapy of malignant melanoma of soft parts., Cancer Gene Ther.
    Adachi et al., 2002, Expression of MRP4 confers resistance to ganciclovir and compromises bystander cell killing., J. Biol. Chem.
    Khallou-Laschet et al., 2006, The proatherogenic role of T cells requires cell division and is dependent on the stage of the disease., Arterioscler. Thromb. Vasc. Biol.

  • TTD: Ganciclovir

    • Version: 2020.06.01

    Alternate Names:
    D05ARP TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL182

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21